Literature DB >> 1370302

Carboxyl-terminal and central regions of human immunodeficiency virus-1 NEF recognized by cytotoxic T lymphocytes from lymphoid organs. An in vitro limiting dilution analysis.

F Hadida1, A Parrot, M P Kieny, B Sadat-Sowti, C Mayaud, P Debre, B Autran.   

Abstract

Cytotoxic T lymphocytes (CTL) specific for human immunodeficiency virus (HIV) proteins have been analyzed in lymphoid organs from seropositive patients. Indeed, an active HIV replication coexists with a major CD8+ lymphocytic infiltration in these organs. We have shown in a previous report that HIV-seropositive patients lungs were infiltrated by HIV specific CD8+ lymphocytes. In the present report, we show that HIV-specific CTL responses can also be detected in lymph nodes and spleens, and were mainly directed against the ENV, GAG, and NEF HIV-1 proteins. The primary NEF-specific CTL responses were further characterized by epitope mapping. Determination of epitope-specific CTL frequencies were performed by limiting dilution analysis. Our results indicated that, in addition to the central region of NEF (AA66-148), a new immunodominant region is recognized by CTL. This region corresponds to the carboxyl-terminal domain of NEF (amino acids 182-206). AA182-206 is recognized in association with at least two common human histocompatibility leukocyte antigen (HLA) molecules (HLA-A1 and B8), with clonal frequencies of one CTL per 10(-5) to 10(-6) splenic lymphocytes. Our data indicate that lymphoid organs may represent a major reservoir for in vivo activated HIV-specific CTL. Furthermore, the carboxyl-terminal domain of NEF was found to be conserved among several HIV strains. Therefore, our finding is of interest for further HIV vaccines development.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1370302      PMCID: PMC442818          DOI: 10.1172/JCI115585

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  34 in total

1.  Prediction of immunodominant helper T cell antigenic sites from the primary sequence.

Authors:  H Margalit; J L Spouge; J L Cornette; K B Cease; C Delisi; J A Berzofsky
Journal:  J Immunol       Date:  1987-04-01       Impact factor: 5.422

2.  Production of interleukins in human immunodeficiency virus-1-replicating lymph nodes.

Authors:  D Emilie; M Peuchmaur; M C Maillot; M C Crevon; N Brousse; J F Delfraissy; J Dormont; P Galanaud
Journal:  J Clin Invest       Date:  1990-07       Impact factor: 14.808

3.  Limiting dilution assays for the determination of immunocompetent cell frequencies. I. Data analysis.

Authors:  C Taswell
Journal:  J Immunol       Date:  1981-04       Impact factor: 5.422

4.  HTLV-III/LAV viral antigens in lymph nodes of homosexual men with persistent generalized lymphadenopathy and AIDS.

Authors:  K Tenner-Racz; P Racz; M Bofill; A Schulz-Meyer; M Dietrich; P Kern; J Weber; A J Pinching; F Veronese-Dimarzo; M Popovic
Journal:  Am J Pathol       Date:  1986-04       Impact factor: 4.307

5.  Mapping the fine specificity of a cytolytic T cell response to HIV-1 nef protein.

Authors:  S Koenig; T R Fuerst; L V Wood; R M Woods; J A Suzich; G M Jones; V F de la Cruz; R T Davey; S Venkatesan; B Moss
Journal:  J Immunol       Date:  1990-07-01       Impact factor: 5.422

6.  Evidence for a cytotoxic T-lymphocyte alveolitis in human immunodeficiency virus-infected patients.

Authors:  B Autran; C M Mayaud; M Raphael; F Plata; M Denis; A Bourguin; J M Guillon; P Debre; G Akoun
Journal:  AIDS       Date:  1988-06       Impact factor: 4.177

7.  HIV-specific cytotoxic T lymphocytes in seropositive individuals.

Authors:  B D Walker; S Chakrabarti; B Moss; T J Paradis; T Flynn; A G Durno; R S Blumberg; J C Kaplan; M S Hirsch; R T Schooley
Journal:  Nature       Date:  1987 Jul 23-29       Impact factor: 49.962

8.  AIDS virus-specific cytotoxic T lymphocytes in lung disorders.

Authors:  F Plata; B Autran; L P Martins; S Wain-Hobson; M Raphaël; C Mayaud; M Denis; J M Guillon; P Debré
Journal:  Nature       Date:  1987 Jul 23-29       Impact factor: 49.962

9.  An immunodominant epitope of the human immunodeficiency virus envelope glycoprotein gp160 recognized by class I major histocompatibility complex molecule-restricted murine cytotoxic T lymphocytes.

Authors:  H Takahashi; J Cohen; A Hosmalin; K B Cease; R Houghten; J L Cornette; C DeLisi; B Moss; R N Germain; J A Berzofsky
Journal:  Proc Natl Acad Sci U S A       Date:  1988-05       Impact factor: 11.205

10.  Detection of cytotoxic T lymphocytes specific for synthetic peptides of gp160 in HIV-seropositive individuals.

Authors:  M Clerici; D R Lucey; R A Zajac; R N Boswell; H M Gebel; H Takahashi; J A Berzofsky; G M Shearer
Journal:  J Immunol       Date:  1991-04-01       Impact factor: 5.422

View more
  26 in total

1.  Emergence and kinetics of simian immunodeficiency virus-specific CD8(+) T cells in the intestines of macaques during primary infection.

Authors:  R S Veazey; M C Gauduin; K G Mansfield; I C Tham; J D Altman; J D Lifson; A A Lackner; R P Johnson
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

Review 2.  Cellular and humoral antigenic epitopes in HIV and SIV.

Authors:  D F Nixon; K Broliden; G Ogg; P A Broliden
Journal:  Immunology       Date:  1992-08       Impact factor: 7.397

Review 3.  Class I HLA-restricted cytotoxic T lymphocyte responses against malaria--elucidation on the basis of HLA peptide binding motifs.

Authors:  D L Doolan; B Wizel; S L Hoffman
Journal:  Immunol Res       Date:  1996       Impact factor: 2.829

4.  Computer simulations to predict the availability of peptides with known HLA class I motifs possibly generated by proteolysis of HIV-1 proteins in infected cells.

Authors:  Y Becker
Journal:  Virus Genes       Date:  1995       Impact factor: 2.332

5.  Genetic drift can dominate short-term human immunodeficiency virus type 1 nef quasispecies evolution in vivo.

Authors:  U Plikat; K Nieselt-Struwe; A Meyerhans
Journal:  J Virol       Date:  1997-06       Impact factor: 5.103

6.  Human immunodeficiency virus type 1-specific cytotoxic T lymphocytes release gamma interferon, tumor necrosis factor alpha (TNF-alpha), and TNF-beta when they encounter their target antigens.

Authors:  C Jassoy; T Harrer; T Rosenthal; B A Navia; J Worth; R P Johnson; B D Walker
Journal:  J Virol       Date:  1993-05       Impact factor: 5.103

7.  Cytotoxic T lymphocyte activity and CD8 subpopulations in children at risk of HIV infection.

Authors:  M C Aldhous; K C Watret; J Y Mok; A G Bird; K S Froebel
Journal:  Clin Exp Immunol       Date:  1994-07       Impact factor: 4.330

8.  Increased expression of interferon-gamma in hyperplastic lymph nodes from HIV-infected patients.

Authors:  M J Boyle; M F Berger; M Tschuchnigg; J E Valentine; B G Kennedy; M Divjak; D A Cooper; J J Turner; R Penny; W A Sewell
Journal:  Clin Exp Immunol       Date:  1993-04       Impact factor: 4.330

9.  Characterization of the primary structure of T cell receptor beta chains in cells infiltrating the salivary gland in the sicca syndrome of HIV-1 infection. Evidence of antigen-driven clonal selection suggested by restricted combinations of V beta J beta gene segment usage and shared somatically encoded amino acid residues.

Authors:  E Dwyer; S Itescu; R Winchester
Journal:  J Clin Invest       Date:  1993-07       Impact factor: 14.808

10.  Oligoclonal expansion of HIV-specific cytotoxic CD8 T lymphocytes in the skin of HIV-1-infected patients with cutaneous pseudolymphoma.

Authors:  H Bachelez; F Hadida; C Parizot; B Flageul; M Kemula; L Dubertret; P Debree; G Gorochov
Journal:  J Clin Invest       Date:  1998-06-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.